From: A three-country comparison of psychotropic medication prevalence in youth
 | US (n = 127,157) | Netherlands (n = 110,944) | Germany (n = 356,520) | ||||||
---|---|---|---|---|---|---|---|---|---|
Age (yr) | Male | Female | Total* | Male | Female | Total* | Male | Female | Total* |
0–4 | 0.14 | 0.06 | 0.10 | 0.02 | 0.02 | 0.02 | 0.03 | 0.00 | 0.02 |
 | 0.10–0.19 | 0.04–0.09 | 0.10–0.10 | 0.00–0.06 | 0.01–0.07 | 0.02–0.02 | 0.01–0.05 | 0.00–0.01 | 0.01–0.02 |
5–9 | 2.24 | 0.74 | 1.51 | 0.30 | 0.09 | 0.20 | 0.13 | 0.09 | 0.11 |
 | 1.99–2.50 | 0.59–0.90 | 1.50–1.52 | 0.22–0.41 | 0.05–0.16 | 0.19–0.20 | 0.10–0.17 | 0.06–0.12 | 0.11–0.11 |
10–14 | 4.67 | 3.26 | 3.98 | 0.57 | 0.30 | 0.44 | 0.18 | 0.09 | 0.14 |
 | 4.26–5.11 | 2.91–3.64 | 3.97–3.99 | 0.45–0.71 | 0.22–0.41 | 0.43–0.44 | 0.14–0.22 | 0.07–0.12 | 0.13–0.14 |
15–19 | 5.03 | 5.21 | 5.12 | 1.16 | 1.74 | 1.44 | 0.29 | 0.58 | 0.43 |
 | 4.53–5.56 | 4.77–5.68 | 5.11–5.13 | 1.00–1.34 | 1.54–1.96 | 1.44–1.45 | 0.24–0.34 | 0.51–0.65 | 0.43–0.43 |
Total* | 3.06 | 2.34 | 2.71 | 0.52 | 0.54 | 0.53 | 0.16 | 0.19 | 0.17 |
 | 3.06–3.07 | 2.34–2.34 | 2.71–2.71 | 0.52–0.52 | 0.54–0.54 | 0.53–0.53 | 0.16–0.16 | 0.19–0.19 | 0.17–0.18 |